Literature DB >> 29669194

Racial Disparities in the Incidence of Primary Chronic Cutaneous Lupus Erythematosus in the Southeastern US: The Georgia Lupus Registry.

Cristina Drenkard1, Sareeta Parker2, Laura D Aspey1, Caroline Gordon3, Charles G Helmick4, Gaobin Bao1, S Sam Lim1.   

Abstract

OBJECTIVE: Relative to studies of systemic lupus erythematosus (SLE), epidemiologic studies of chronic cutaneous lupus erythematosus (CCLE) are rare and are limited to populations with no racial diversity. We sought to provide minimum estimates of the incidence of primary CCLE (CCLE in the absence of SLE) in a population comprised predominantly of white individuals and black individuals in the southeastern region of the US.
METHODS: The Georgia Lupus Registry allowed for the use of multiple sources for case-finding, including dermatology and rheumatology practices, multispecialty health care facilities, and dermatopathology reports. Cases with a clinical or clinical/histologic diagnosis of CCLE were classified as definite. Cases ascertained exclusively from dermatopathology reports were categorized as probable. Age-standardized incidence rates stratified by sex and race were calculated for discoid lupus erythematosus (DLE) in particular and for CCLE in general.
RESULTS: The overall age-adjusted estimates for combined (definite and probable) CCLE were 3.9 per 100,000 person-years (95% confidence interval [95% CI] 3.4-4.5). The overall age-adjusted incidences of definite and combined DLE were 2.9 (95% CI 2.4-3.4) and 3.7 (95% CI 3.2-4.3) per 100,000 person-years, respectively. When capture-recapture methods were used, the age-adjusted incidence of definite DLE increased to 4.0 (95% CI 3.2-4.3). The black:white and female:male incidence ratios for definite DLE were 5.4 and 3.1, respectively.
CONCLUSION: Our findings underscore the striking racial disparities in susceptibility to primary CCLE, with black individuals having a 3-fold to 5-fold increased incidence of CCLE in general, and DLE in particular, compared with white individuals. The observed sex differences were consistent with those reported previously, with a 3 times higher risk of DLE in women compared with men.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Year:  2019        PMID: 29669194      PMCID: PMC6193862          DOI: 10.1002/acr.23578

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  25 in total

1.  Confidence intervals for directly standardized rates: a method based on the gamma distribution.

Authors:  M P Fay; E J Feuer
Journal:  Stat Med       Date:  1997-04-15       Impact factor: 2.373

Review 2.  Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.

Authors:  Richard D Sontheimer
Journal:  Autoimmun Rev       Date:  2004-11-12       Impact factor: 9.754

Review 3.  Clinical manifestations of cutaneous lupus erythematosus.

Authors:  Victoria P Werth
Journal:  Autoimmun Rev       Date:  2005-02-10       Impact factor: 9.754

4.  Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program.

Authors:  Emily C Somers; Wendy Marder; Patricia Cagnoli; Emily E Lewis; Peter DeGuire; Caroline Gordon; Charles G Helmick; Lu Wang; Jeffrey J Wing; J Patricia Dhar; James Leisen; Diane Shaltis; W Joseph McCune
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

5.  The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry.

Authors:  S Sam Lim; A Rana Bayakly; Charles G Helmick; Caroline Gordon; Kirk A Easley; Cristina Drenkard
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

6.  Capture-recapture methods for assessing the completeness of case ascertainment when using multiple information sources.

Authors:  J T Wittes; T Colton; V W Sidel
Journal:  J Chronic Dis       Date:  1974-02

7.  Distinctive cutaneous subsets in the spectrum of lupus erythematosus.

Authors:  J N Gilliam; R D Sontheimer
Journal:  J Am Acad Dermatol       Date:  1981-04       Impact factor: 11.527

8.  Predictors of low quality of life in patients with discoid lupus.

Authors:  N M Teske; Z E Cardon; M E Ogunsanya; X Li; B Adams-Huet; B F Chong
Journal:  Br J Dermatol       Date:  2017-09-27       Impact factor: 9.302

Review 9.  Lupus erythematosus: systemic and cutaneous manifestations.

Authors:  Naomi Rothfield; Richard D Sontheimer; Megan Bernstein
Journal:  Clin Dermatol       Date:  2006 Sep-Oct       Impact factor: 3.541

10.  A clinical and epidemiological study of lupus erythematosus at a tertiary referral dermatology clinic in Korea.

Authors:  Y I Bae; S-J Yun; J-B Lee; S-J Kim; Y H Won; S-C Lee
Journal:  Lupus       Date:  2009-11-02       Impact factor: 2.911

View more
  16 in total

1.  Analysis of clinical characteristics of drug-induced cutaneous lupus erythematosus in men.

Authors:  Amy J Petty; Adela R Cardones; Anne L Marano
Journal:  J Am Acad Dermatol       Date:  2020-03-07       Impact factor: 11.527

2.  Chronic Cutaneous Lupus Erythematosus: Depression Burden and Associated Factors.

Authors:  Jennifer Hong; Laura Aspey; Gaobin Bao; Tamara Haynes; S Sam Lim; Cristina Drenkard
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

3.  Burden of Systemic Lupus Erythematosus on Work Productivity and Daily Living Activity: A Cross-Sectional Study Among Malaysian Multi-Ethnic Cohort.

Authors:  Fakhriah Abu Bakar; Syahrul Sazliyana Shaharir; Rozita Mohd; Mohd Shahrir Mohamed Said; Sakthiswary Rajalingham; Kong Wei Yen
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

4.  Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation.

Authors:  Allison C Billi; Feiyang Ma; Olesya Plazyo; Mehrnaz Gharaee-Kermani; Rachael Wasikowski; Grace A Hile; Xianying Xing; Christine M Yee; Syed M Rizvi; Mitra P Maz; Celine C Berthier; Fei Wen; Lam C Tsoi; Matteo Pellegrini; Robert L Modlin; Johann E Gudjonsson; J Michelle Kahlenberg
Journal:  Sci Transl Med       Date:  2022-04-27       Impact factor: 19.319

Review 5.  Cutaneous Lupus Erythematosus: Progress and Challenges.

Authors:  Amy J Petty; Lauren Floyd; Christopher Henderson; Matilda W Nicholas
Journal:  Curr Allergy Asthma Rep       Date:  2020-04-04       Impact factor: 4.806

6.  Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta-Analysis of the Centers for Disease Control and Prevention National Lupus Registries.

Authors:  Peter M Izmirly; Hilary Parton; Lu Wang; W Joseph McCune; S Sam Lim; Cristina Drenkard; Elizabeth D Ferucci; Maria Dall'Era; Caroline Gordon; Charles G Helmick; Emily C Somers
Journal:  Arthritis Rheumatol       Date:  2021-04-23       Impact factor: 15.483

7.  SLE: reconciling heterogeneity.

Authors:  Michael D Lockshin; Medha Barbhaiya; Peter Izmirly; Jill P Buyon; Mary K Crow
Journal:  Lupus Sci Med       Date:  2019-02-04

Review 8.  Update on lupus epidemiology: advancing health disparities research through the study of minority populations.

Authors:  Cristina Drenkard; S Sam Lim
Journal:  Curr Opin Rheumatol       Date:  2019-11       Impact factor: 5.006

Review 9.  Rheumatic diseases in Africa.

Authors:  Olufemi Adelowo; Girish M Mody; Mohammed Tikly; Omondi Oyoo; Samy Slimani
Journal:  Nat Rev Rheumatol       Date:  2021-04-13       Impact factor: 20.543

10.  Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program.

Authors:  Peter Izmirly; Jill Buyon; H Michael Belmont; Sara Sahl; Isabella Wan; Jane Salmon; Anca Askanase; Joan M Bathon; Laura Geraldino-Pardilla; Yousaf Ali; Ellen Ginzler; Chaim Putterman; Caroline Gordon; Charles Helmick; Hilary Parton
Journal:  Lupus Sci Med       Date:  2019-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.